An integrated approach for deeper insight with both open and closed claims data
Pharma teams are under sharper financial scrutiny and policy pressure than they've been in years,...
Pharma teams are under sharper financial scrutiny and policy pressure than they've been in years,...
Open claims and closed payer claims data are essential for understanding the status and activities...
Understanding mortality in taXonomy and the importance of post mortem activity This is the third...
A better way to measure healthcare costs in closed claims data This is the second post in our...
How clinical data linkage closes evidence gaps in real-world data Clinical data linkage helps...
Artificial intelligence is moving quickly into healthcare research, but one question still comes...
One in nine Americans age 65 and older has Alzheimer’s disease (AD), a devastating illness that...
RWE and HEOR teams face increasing pressure to produce evidence that holds up beyond internal...
Healthcare marketing has reached an inflection point and for years, success was defined by reach:...
Capturing the true complexity of psoriasis in the real world Psoriasis is a common chronic...
Pharma teams are under sharper financial scrutiny and policy pressure than they've been in years, and the decisions being asked of them (pricing, access, launch strategy, lifecycle planning) all hinge on a comprehensive patient journey.